To investigate the role of FGL1 in the response to sorafenib in HCC cell lines, we modulated FGL1 expression levels in high FGL1-expressing HCC cells, Huh7 and Hep3B, via FGL1 siRNA. The gene discussed is FGL1; the disease is hepatocellular carcinoma.